Mobile Cardiac Telemetry Systems Market, By Type (Single Channel and Multi-Channel), By Technology (Lead Based and Patch Based), By Cellular Connection (Wireless (WIFI) and Bluetooth (BT)), By End-user (Hospitals, Cardiac Centers, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis, and Forecast till 2029

Mobile Cardiac Telemetry Systems Market accounted for USD 602.4 Million in 2020 and is estimated to be USD 1548.6 Million by 2029 and is anticipated to register a CAGR of 11.1%

Mobile cardiac telemetry (MCT) is real-time cardiac monitoring introduced with cutting-edge technology. It offers a reliable and convenient monitoring of cardiac rate in patients with cardiac diseases. MCT monitoring devices are advanced developed devices. They automatically detect and transmit ECG rhythms without patient involvement to a distant diagnostic monitoring laboratory for up to 30 days.

Rising incidence of chronic diseases

The increasing rate of cardiac diseases is the major factor of deaths across the globe. For instance, as per the data published by WHO (World Health Organization), every year 17.7 million people die due to cardiovascular diseases. Out of these deaths, 7.4 million deaths were predicted owing to coronary heart diseases while 6.5 million due to strokes. Increased use of caffeine coupled with changing lifestyle & stress are causing an increase in blood pressure, hence growing the risks of getting a cardiac disease. Additionally, the global healthcare industry is accelerating on the account of rising disposable income, growing awareness on cardiac diseases, tobacco use, obesity and unhealthy diet, physical inactivity and harmful use of alcohol. Therefore, this will upsurge the risks of cardiac diseases in the existing generation which is further going to definitely affect the growth of the global mobile cardiac telemetry systems market.

Rising focus on wearable devices for real-time patient monitoring

The demand for real-time monitoring devices is swelling to allow early detection of cardiac diseases, which can help patients in gaining immediate medical attention. For example, Apple Watch which is a wearable ECG monitoring products offers real-time monitoring on an outpatient basis. The accessibility of such devices will expand the business scope for the vendors. Thus, the increasing focus on wearable products for real-time patient monitoring will have an optimistic impact on the overall market growth.

However, the basic reason for low adoption of these devices is because the technical component needs considerably superior costs including specialized education & training for staff, equipment costs, labor costs, maintenance costs, supply costs combined with the time required to generate the final results of the study. Additionally, the presence of cheaper and more efficient alternatives are projected to slow down the growth of mobile cardiac telemetry systems in the coming years.

The global mobile cardiac telemetry systems market is segmented based on the type, technology, cellular connection, end-user, and region.

On the basis of the type, the global mobile cardiac telemetry systems market is segmented into single-channel and multi-channel. Based on the technology, the target market is segmented into lead-based and patch-based. Based on the cellular connection, the target market is classified into wireless (WIFI) and bluetooth (BT). Based on the end-user, the target market is classified into hospitals, cardiac centres, and others.

In the region, the global mobile cardiac telemetry systems market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America led the market for mobile cardiac telemetry systems with a maximum revenue share in 2019, owing to the geriatric population, the prevalence of cardiac disorders, and increasing healthcare expenditure. For instance, as per the Administration for Community Living, there has been a 33% growth in the geriatric population in the U.S. in the previous years. Further, the availability of major service providers with advanced healthcare solutions is projected to influence the global market growth over the forecast period. The Asia Pacific is anticipated to register lucrative growth during the forecast period. Factors such as dietary habits and growing adoption of a sedentary lifestyle resulting in physical inactivity are funding to the raised cardiovascular morbidities in the region. According to the Ministry of Health Labor and Welfare, evert year around 170,000 deaths were endorsed to cardiovascular diseases in Japan.

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2029.  For the purpose of this study, has segmented the global mobile cardiac telemetry systems market report based on type, technology, cellular connection, end-user, and region.

Global Mobile Cardiac Telemetry Systems Market, By Type:

• Single Channel
• Multi-Channel

 Global Mobile Cardiac Telemetry Systems Market, By Technology:

• Lead Based
• Patch Based

Global Mobile Cardiac Telemetry Systems Market, By Cellular Connection:

• Wireless (WIFI)
• Bluetooth (BT)

Global Mobile Cardiac Telemetry Systems Market, By End-user:

• Hospitals
• Cardiac Centers
• Others

Global Mobile Cardiac Telemetry Systems Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating in the global mobile cardiac telemetry systems market include BioTelemetry, Inc., ScottCare, Biotricity Inc., Telerhythmics LLC, Applied Cardiac Systems Inc., Medicomp Inc., Welch Allyn, Preventice Solutions, Zoll Medical Corporation, and iRhythm Technologies, Inc. Prominent market players are involved in strategic collaborations, new product launch, and regional expansions to expand their market penetration.

For instance, in July 2019, Biotelemetry acquired ADEA Medical AB. This acquisition is associated with BioTelemetry’s longer-term strategy to spread its international business in the Nordics and other European countries.

• BioTelemetry, Inc.
• ScottCare
• Biotricity Inc.
• Telerhythmics LLC
• Applied Cardiac Systems Inc.
• Medicomp Inc.
• Welch Allyn
• Preventice Solutions
• Zoll Medical Corporation
• iRhythm Technologies, Inc.